- Home
- PYPD vs OCC Comparison
PYPD vs OCC Comparison
Compare PYPD & OCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- OCC
- Stock Information
- Founded
- PYPD 2008
- OCC 1983
- Country
- PYPD Israel
- OCC United States
- Employees
- PYPD N/A
- OCC N/A
- Industry
- PYPD Medical/Dental Instruments
- OCC Telecommunications Equipment
- Sector
- PYPD Health Care
- OCC Industrials
- Exchange
- PYPD Nasdaq
- OCC Nasdaq
- Market Cap
- PYPD 16.5M
- OCC 17.2M
- IPO Year
- PYPD 2020
- OCC 1996
- Fundamental
- Price
- PYPD $2.93
- OCC $2.20
- Analyst Decision
- PYPD Strong Buy
- OCC
- Analyst Count
- PYPD 2
- OCC 0
- Target Price
- PYPD $12.00
- OCC N/A
- AVG Volume (30 Days)
- PYPD 28.7K
- OCC 10.2K
- Earning Date
- PYPD 02-12-2025
- OCC 12-27-2024
- Dividend Yield
- PYPD N/A
- OCC N/A
- EPS Growth
- PYPD N/A
- OCC N/A
- EPS
- PYPD N/A
- OCC N/A
- Revenue
- PYPD N/A
- OCC $64,517,697.00
- Revenue This Year
- PYPD N/A
- OCC N/A
- Revenue Next Year
- PYPD N/A
- OCC N/A
- P/E Ratio
- PYPD N/A
- OCC N/A
- Revenue Growth
- PYPD N/A
- OCC N/A
- 52 Week Low
- PYPD $2.37
- OCC $2.02
- 52 Week High
- PYPD $9.20
- OCC $3.53
- Technical
- Relative Strength Index (RSI)
- PYPD 33.37
- OCC 40.87
- Support Level
- PYPD $2.37
- OCC $2.05
- Resistance Level
- PYPD $3.13
- OCC $2.24
- Average True Range (ATR)
- PYPD 0.24
- OCC 0.13
- MACD
- PYPD -0.06
- OCC 0.00
- Stochastic Oscillator
- PYPD 19.30
- OCC 21.05
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, broadcast, oil & gas, and others.